# Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson

> **NCT01779869** · PHASE4 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 16 (actual)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DRUG:** Regadenoson

## Key facts

- **NCT ID:** NCT01779869
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01779869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01779869, "Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01779869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*